Population-based Brest Stroke Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

15000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The registry is the main objective exhaustive list of cases validated stroke brain on a geographical area defined to calculate an incidence.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions

NCT05685069

Silent Stroke Silent Cerebral Infarct Covert Brain Infarct +3 more

RECRUITING

Neurocognitive Impairment After Ischemic Stroke

NCT06262529

Acute Ischemic Stroke

RECRUITING NA

Korean Transient Ischemic Attack eXpression Registry

NCT01870531

Transient Ischemic Attack

COMPLETED

Prediction of Patient-specific Outcomes After Interventional neuroRadiology Procedures

NCT04504695

Aneurysmal Disease Stroke

UNKNOWN

National Cerebral and Cardiovascular Center (NCVC) Stroke Registry

NCT02251665

Stroke, Acute

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective of Brest Stroke Registry is to regroup all confirmed cases of stroke over a defined geographical zone in order to calculate an incidence.

There are three prospective medium-term goals:

\- In respect with public health epidemiology:

1. To obtain incidence data and evaluate the regional and international divergences
2. To obtain the mortality data in short and long term. Since the onset of the registry, it has been implemented a study on the mortality of stroke patients of Brest Registry. This study has been realized independently for both types of stroke, i.e. ischemic and hemorrhagic, with different caused mortality. This mortality was studied at medium-term (≤ 28 days) as well as at long-term (\> 28 days). There will be a collaboration project between Public Health Surveillance (InVS), Brest University Hospital and Rennes network on all causes of death.
3. Pharmaco-epidemiology

In clinical terms, the registry offers an opportunity to do an inventory of all current practices (diagnosis, therapies and the subsidiaries) and propose in this manner the best management of stroke. This strategy is in line with the pilot programs deployed by the French High Health Authority (HAS) for improvement of quality and safety of the health care. The bleeding risk associated with anticoagulants and anti-platelet agents in people of Brest as well as that of Dijon and Lille (in collaboration with their respective registry) will be analyzed.

This study has gained a particular characteristic since 2012 with emerging new oral anticoagulants (OAC) which have shown less associated bleeding risks compared with vitamin K antagonists (randomized controlled trials).

•In terms of clinical research :

1. Study the impacted consequences of stroke by socio-economic characteristics of the territories in the Pays de Brest
2. Identify short and long term clinical predictors of mortality in patients who have had a hemorrhagic stroke.
3. To identify clinical predictors of mortality in the short and long-term patients with ischemic stroke.
4. To identify genetic predictors of mortality and long-term recurrence of patients with ischemic stroke
5. Identify stroke identification algorithm from existing databases

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral (CVAs) Ischemic Cerebrovascular Accident Stroke Brain Ischemia Brain Hemorrhage Ischemic Stroke Hemorrhagic Stroke Cerebrovascular Disorders Transient Ischemic Attack (TIA)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnostic validated for one of the following pathologies:
* Ischemic stroke,
* Non-traumatic intracranial hematoma
* Cerebral venous thrombosis Diagnostic after December 31, 2007 Age \> 15 years on the date of the diagnostic Patient domiciled at the time of the diagnostic in one of the 79 communes defined beforehand

Exclusion Criteria

* Age ≤ 15 years
* Validated diagnosis (see below, § 4.2.2) of aneurysmal subarachnoid hemorrhage cerebrovascular
* Diagnosis made before 1 January 2008
* Unconfirmed diagnosis
* Patient domiciled outside the previously defined area of residence

Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No